REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001104659-26-039613 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
100
Total Value
$77,727.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Sale | 1 | $771.32 | $771.32 | 17,702 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 3 | $772.76 | $2,318.28 | 17,699 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 8 | $773.59 | $6,188.72 | 17,691 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 8 | $774.58 | $6,196.64 | 17,683 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 14 | $775.58 | $10,858.12 | 17,669 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 13 | $776.62 | $10,096.06 | 17,656 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 9 | $777.42 | $6,996.78 | 17,647 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 4 | $778.24 | $3,112.96 | 17,643 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 40 | $779.71 | $31,188.40 | 17,603 | Direct | โ | View Details |